Published on in Vol 6, No 2 (2017): February

Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b)

Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b)

Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b)

Mara Buijs   1 , MD ;   Krijn P van Lienden   2 , MD, PhD ;   Peter GK Wagstaff   1 , MD, PhD ;   Matthijs JV Scheltema   1 , MD ;   Daniel M de Bruin   3 , MSc, PhD ;   Patricia J Zondervan   1 , MD ;   Otto M van Delden   2 , MD, PhD ;   Ton G van Leeuwen   3 , MD, PhD ;   Jean JMCH de la Rosette   1 , MD, PhD ;   M Pilar Laguna   1 , MD, PhD

1 Academic Medical Center, Department of Urology, University of Amsterdam, Amsterdam, Netherlands

2 Academic Medical Center, Department of Radiology, University of Amsterdam, Amsterdam, Netherlands

3 Academic Medical Center, Department of Biomedical Engineering and Physics, University of Amsterdam, Amsterdam, Netherlands

Corresponding Author:

  • Mara Buijs, MD
  • Academic Medical Center
  • Department of Urology
  • University of Amsterdam
  • Meibergdreef 9
  • Amsterdam
  • Netherlands
  • Phone: 31 20 5665793
  • Fax: 31 20 5669585
  • Email: m.buijs@amc.uva.nl